(ZNTL) – Business Wire
-
Immunome Exclusively Licenses Zentalis ROR1 Antibody-Drug Conjugate and Proprietary Technology Platform
-
Newman Ferrara LLP Announces Corporate Governance Investigations of Zentalis Pharmaceuticals, Inc. (ZNTL)
-
Lengo Therapeutics Appoints Enoch K. Kariuki as Chief Executive Officer
Back to ZNTL Stock Lookup